Journal of Clinical Oncology

Reply to: Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?

S Skander Jemaa (6Genentech, Inc., South San Francisco, United States) T Thomas Bengtsson (Skander Jemaa, MS, Genentech, Inc, South San Francisco, CA; Thomas Bengtsson, PhD, University of California, Berkeley, CA; and Thomas Bengtsson, PhD, Genentech, Inc, South San Francisco, CA) R Richard A.D. Carano (Skander Jemaa, MS, Genentech, Inc, South San Francisco, CA; Thomas Bengtsson, PhD, University of California, Berkeley, CA; and Thomas Bengtsson, PhD, Genentech, Inc, South San Francisco, CA)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 11
Published April 10, 2025
Pages 1396-1397
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

S

Skander Jemaa

6Genentech, Inc., South San Francisco, United States

T

Thomas Bengtsson

Skander Jemaa, MS, Genentech, Inc, South San Francisco, CA; Thomas Bengtsson, PhD, University of California, Berkeley, CA; and Thomas Bengtsson, PhD, Genentech, Inc, South San Francisco, CA

R

Richard A.D. Carano

Skander Jemaa, MS, Genentech, Inc, South San Francisco, CA; Thomas Bengtsson, PhD, University of California, Berkeley, CA; and Thomas Bengtsson, PhD, Genentech, Inc, South San Francisco, CA

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001